MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0233460

Медицинская библиотека · PloS one · 2020

Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry disease.

Mauhin Wladimir, Benveniste Olivier, Amelin Damien, Montagner Clémence, Lamari Foudil, Caillaud Catherine, Douillard Claire, Dussol Bertrand, Leguy-Seguin Vanessa, D'Halluin Pauline, Noel Esther, Zenone Thierry, Matignon Marie, Maillot François, Ly Kim-Heang, Besson Gérard, Willems Marjolaine, Labombarda Fabien, Masseau Agathe, Lavigne Christian, Lacombe Didier, Maillard Hélène, Lidove Olivier

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUD: Fabry disease (OMIM #301 500), the most prevalent lysosomal storage disease, is caused by enzymatic defects in alpha-galactosidase A (GLA gene; Xq22.1). Fabry disease has historically been characterized by progressive renal failure, early stroke and hypertrophic cardiomyopathy, with a diminished life expectancy. A nonclassical phenotype has been described with an almost exclusive cardiac involvement. Specific therapies with enzyme substitution or chaperone molecules are now available depending on the mutation carried. Numerous clinical and fundamental studies have been conducted without stratifying patients by phenotype or severity, despite different prognoses and possible different pathophysiologies. We aimed to identify a simple and clinically relevant way to classify and stratify patients according to their disease severity.

METHODS

Based on data from the French Fabry Biobank and Registry (FFABRY; n = 104; 54 males), we applied unsupervised multivariate statistics to determine clusters of patients and identify clinical criteria that would allow an effective classification of adult patients. Thanks to these criteria and empirical clinical considerations we secondly elaborate a new score that allow the severity stratification of patients.

RESULTS

We observed that the absence of acroparesthesia or cornea verticillata is sufficient to classify males as having the nonclassical phenotype. We did not identify criteria that significantly cluster female patients. The classical phenotype was associated with a higher risk of severe renal (HR = 35.1; p <10-3) and cardiac events (HR = 4.8; p = 0.008) and a trend toward a higher risk of severe neurological events (HR = 7.7; p = 0.08) compared to nonclassical males. Our simple, rapid and clinically-relevant FFABRY score gave concordant results with the validated MSSI.

CONCLUSION

Acroparesthesia and cornea verticillata are simple clinical criteria that efficiently stratify Fabry patients, defining 3 different groups: females and males with nonclassical and classical phenotypes of significantly different severity. The FFABRY score allows severity stratification of Fabry patients.

Для цитирования: Mauhin Wladimir, Benveniste Olivier, Amelin Damien, Montagner Clémence, Lamari Foudil, Caillaud Catherine, Douillard Claire, Dussol Bertrand, Leguy-Seguin Vanessa, D'Halluin Pauline, Noel Esther, Zenone Thierry, Matignon Marie, Maillot François, Ly Kim-Heang, Besson Gérard, Willems Marjolaine, Labombarda Fabien, Masseau Agathe, Lavigne Christian, Lacombe Didier, Maillard Hélène, Lidove Olivier. Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry disease.. PloS one. 2020. DOI: 10.1371/journal.pone.0233460.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.